在上升性大动脉动脉瘤患者中,血中的siruin 1和siruin 2水平 - - 一项比较研究
Jan Krekora1, Oliwia Matuszewska-Brycht2, Jolanta Fryczak3
12nd Department of Cardiology, Medical University of Lodz, Poland. ejkrekora@op.pl.
Cardiology journal
|October 14, 2025
概括
在患有上升性大动脉动脉瘤 (AA) 的患者中,血sirtuin 1 (SIRT1) 和sirtuin 2 (SIRT2) 水平没有显著差异. 然而,一种趋势表明AA患者的SIRT1较高,特别是那些没有并发症的患者.
科学领域:
- 心血管研究研究心血管研究
- 生物标志物发现发现
背景情况:
- 在动物和人类组织研究中,Sirtuins显示出对大动脉动脉瘤 (AA) 的保护潜力.
- 之前的研究还没有评估关于AA的人类血Sirtuin水平.
研究的目的:
- 调查血Sirtuin 1 (SIRT1) 和Sirtuin 2 (SIRT2) 水平与人类患者上升AA的存在之间的关联.
主要方法:
- 从患有和没有上升AA的患者的血样本中分析了SIRT1和SIRT2度.
- 用一种酶相关的免疫吸收试验 (ELISA) 来量化Sirtuin水平.
主要成果:
- 在患有上升AA的患者 (n=32) 和对照组 (n=37) 之间,血SIRT1和SIRT2水平没有显著差异.
- 一个趋势表明AA患者的SIRT1水平略高,特别是那些没有冠状动脉疾病,心房动或COPD的患者.
- 与COPD患者相比,在没有COPD的上升AA患者中观察到较高的SIRT2水平 (p=0.04).
结论:
- 血SIRT1和SIRT2水平在具有和没有上升AA的个体之间没有显著差异.
- 在上升的AA患者中,增加SIRT1水平的趋势,特别是那些没有并发症的患者,需要进一步调查.
相关概念视频
Aneurysm II: Clinical Manifestations and Diagnostic Studies
293
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
293
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
405
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
405
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
538
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
538


